Burning Rock Biotech Ltd
BNR- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001792267
No open-market purchases or sales by Burning Rock Biotech Ltd insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $14.7M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Burning Rock Biotech Ltd changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 54 | 86 | +32 |
| Shares | 23.6M | 27.0M | +3.39M (+14.4%) |
| Value | $634.7M | $793.4M | +$158.7M (+25.0%) |
New holders (40)
Institutions that held Burning Rock Biotech Ltd at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (8)
Institutions that held Burning Rock Biotech Ltd at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Casdin Capital, LLC | 847,150 | $22.8M |
| Millennium Management LLC | 106,941 | $2.88M |
| Marshall Wace, LLP | 51,768 | $1.39M |
| Clearbridge Investments, LLC | 33,666 | $906.0K |
| Norges Bank | 20,000 | $538.0K |
| Schonfeld Strategic Advisors LLC | 12,600 | $339.0K |
| D. E. Shaw & Co., Inc. | 12,487 | $336.0K |
| Bank of Montreal | 35 | $1.00K |